
Fortis Malar (FORTISMLR) | Stock Overview & Key Data
Fortis Malar Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹107.94 on April 22, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Fortis Malar FORTISMLR | 1.29B Small-cap | 0.23% | -3.60% | -8.27% | 17.31% | 11.57% | 11.89% | 18.57% | 40.49% |
Max Healthcare MAXHEALTH | 1.19T Large-cap | -2.48% | 0.92% | 3.48% | 20.59% | 7.88% | 44.14% | 224.64% | 998.17% |
Apollo Hospitals APOLLOHOSP | 1.12T Large-cap | 8.11% | 7.84% | 12.17% | 21.81% | 6.16% | 14.03% | 85.60% | 370.74% |
Indraprastha Medical INDRAMEDCO | 41.83B Small-cap | 0.16% | -1.70% | 8.50% | 16.31% | -13.52% | 17.58% | 574.59% | 788.15% |
Shalby SHALBY | 21.86B Small-cap | -2.21% | 2.60% | 1.27% | -0.52% | -12.85% | -26.55% | 63.66% | 129.35% |
Dr. Agarwal's Eye DRAGARWQ | 20.90B Small-cap | -1.56% | 0.84% | 3.99% | 7.08% | -31.32% | 11.02% | 455.17% | 1,691.68% |
Ownership & Short Interest
Fortis Malar Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Fortis Malar would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is FORTISMLR's 52-week high and low?
- In the last 52 weeks, Fortis Malar reached a high of ₹98.70 (on April 4, 2025) and a low of ₹51.01 (on October 25, 2024).
- What is the market cap and P/E ratio for FORTISMLR?
- Curious about Fortis Malar's size and valuation? Its market capitalization stands at 1.29B. When it comes to valuation, the P/E ratio (trailing twelve months) is 27.91, and the forward P/E (looking ahead) is N/A.
- Does FORTISMLR pay dividends? If so, what's the yield?
- Yes, Fortis Malar is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 3.38%, and the company has paid an average of ₹14.17 per share annually over the past 3 years.
- Who are Fortis Malar's main competitors or similar companies to consider before investing?
When looking at Fortis Malar, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Max Healthcare
MAXHEALTH1.19T Healthcare Medical Care Facilities 44.14% 224.64% Apollo Hospitals
APOLLOHOSP1.12T Healthcare Medical Care Facilities 14.03% 85.60% Indraprastha Medical
INDRAMEDCO41.83B Healthcare Medical Care Facilities 17.58% 574.59% Shalby
SHALBY21.86B Healthcare Medical Care Facilities -26.55% 63.66% Dr. Agarwal's Eye
DRAGARWQ20.90B Healthcare Medical Care Facilities 11.02% 455.17% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Fortis Malar Hospitals Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Fortis Malar's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.30%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at 100.00%.
- What is the recent revenue and earnings growth for FORTISMLR?
- Looking at Fortis Malar's growth, its revenue over the trailing twelve months (TTM) was INR205K. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of FORTISMLR stock is held by insiders and institutions?
- Wondering who owns Fortis Malar stock? Company insiders (like executives and directors) hold about 72.33% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.